����������

The director and nurse manager for pediatric emergency mental health services at UMass Memorial Health in Massachusetts share how the health system is helping kids receive treatment that fits their needs.

The Substance Abuse and Mental Health Services Administration this month awarded $131.7 million in grants to programs that connect youth and families to behavioral health services.

The Centers for Disease Control and Prevention Sept. 22 recommended the first maternal vaccine to protect newborns from severe illness from respiratory syncytial virus, the leading cause of hospitalization for U.S. infants.

The Senate Health, Education, Labor and Pensions Committee today voted 14-7 to advance as amended to the full Senate the Bipartisan Primary Care and Health Workforce Expansion Act (S. 2840), legislation that would cut hospitals and health systems to fund community health centers and health care workforce initiatives.

The U.S. infant mortality rate was essentially unchanged in 2021, but the number of deaths rose 2% to 19,928, the Centers for Disease Control and Prevention reported Sept. 12

Based on an AHA-led discussion with hospital leaders, this resource shares strategies to foster equitable practices in maternal care at the patient and organizational level.

A new report from the National Academies of Sciences, Engineering, and Medicine recommends actions to improve access to pediatric subspecialty care

The Centers for Disease Control and Prevention Sept. 5 alerted clinicians to a recent increase in respiratory syncytial virus in the Southeastern U.S., which could signal the beginning of 2023-2024 RSV season nationally.

The Centers for Medicare & Medicaid Services sent to each state letters regarding compliance with federal requirements related to automatic eligibility renewals, known as “ex parte” renewals, under Medicaid and the Children’s Health Insurance Program.

The Food and Drug Administration announced its approval of Pfizer’s Abrysvo (Respiratory Syncytial Virus Vaccine), the first vaccine approved for use in pregnant individuals to prevent lower respiratory tract disease and severe LRTD caused by respiratory syncytial virus in infants from birth through six months of age.

A new report by the Centers for Disease Control and Prevention says 20% of women reported experiences of mistreatment during pregnancy and delivery care, with CDC saying the highest rates reported by Black, Hispanic and multiracial women.

Receiving a COVID-19 mRNA vaccine or booster during pregnancy can benefit pregnant people and their newborn infants, according to findings from a federally funded study published in Vaccine.

U.S. hospital emergency departments have improved many aspects of pediatric readiness since 2013, based on responses by over 3,600 EDs to a 2021 assessment by the National Pediatric Readiness Project, JAMA Network Open reports

The Food and Drug Administration approved the first pill to treat postpartum depression in adults, whose symptoms can range from sadness and loss of energy to cognitive impairment and suicidal ideation. Patients would take the drug (Zurzuvae) for 14 days.

Over 5.6 million women in the US live in maternity care deserts. Read the latest analysis on access to obstetric care through hospitals and providers from the March of Dimes on AHA News.

Suicide accounts for one in five postpartum deaths; one in five women experience a perinatal mental health condition; and over half of pregnant women with depression do not receive treatment, according to a new AHA infographic highlighting the grim statistics surrounding maternal mental health, five ways to improve maternal mental health outcomes and recommended resources for providers.

The AHA yesterday joined 85 national organizations in urging Congress to swiftly pass the Preventing Maternal Deaths Reauthorization Act (H.R.3838/S.2415), bipartisan legislation that would reauthorize federal support for state-based maternal mortality review committees, which review pregnancy-related deaths to identify causes and make recommendations to prevent future mortalities.

The Food and Drug Administration July 13 approved the first daily oral contraceptive pill (norgestrel) for use in the U.S. without a prescription.

The AHA, along with members of the Mental Health Liaison Group, recently voiced support for the Helping Kids Cope Act (H.R. 2412), legislation that would provide Health Resources and Services Administration grants to expand access to pediatric mental and behavioral health services.

Micah Niermann, M.D. discusses how Gillette Children's is reaching their pediatric community and fighting vaccine misinformation.